{"prompt": "['IRB Approval', 'Each investigator or group of investigators at a clinical site must obtain IRB approval for', 'this protocol and submit IRB approval and supporting documentation to the CTSU', 'Regulatory Office before they can be approved to enroll patients. Assignment of site', 'registration status in the CTSU Regulatory Support System (RSS) uses extensive data to', 'make a determination of whether a site has fulfilled all regulatory criteria including but', 'not limited to the following:', 'An active Federal Wide Assurance (FWA) number', 'An active roster affiliation with the Lead Network or a participating organization', 'A valid IRB approval', 'Compliance with all protocol specific requirements.', 'In addition, the site-protocol Principal Investigator (PI) must meet the following criteria:', 'Active registration status', 'The IRB number of the site IRB of record listed on their Form FDA 1572', 'An active status on a participating roster at the registering site.', 'Downloading Site Registration Documents:', 'Site registration forms may be downloaded from the NRG-GU003 protocol page located', \"on the CTSU members' website.\", \"Go to https://www.ctsu.org and log in to the members' area using your CTEP-\", 'IAM username and password', 'Click on the Protocols tab in the upper left of your screen', 'Either enter the protocol # in the search field at the top of the protocol tree, or', 'Click on the NRG Oncology link to expand, then select trial protocol NRG-', 'GU003', 'Click on LPO Documents, select the Site Registration documents link, and', 'download and complete the forms provided.', 'Requirements For NRG-GU003 Site Registration:', 'IRB approval letter (For sites not participating via the NCI CIRB; local IRB', 'documentation, an IRB-signed CTSU IRB Certification Form, Protocol of Human', 'Subjects Assurance Identification/IRB Certification/Declaration of Exemption', 'Form, or combination is accepted)', 'IRB/REB Approved Informed Consent (English and native language versions*)', '*Note: Institutions must provide certification/verification of IRB/REB consent', 'translation to NRG Headquarters (described below).', 'IRB/REB registration number renewal information as appropriate.', 'CTSU RT Facilities Inventory Form', 'NOTE: Per NCI policy all institutions that participate on protocols with a', 'radiation therapy component must participate in the Imaging and Radiation', 'Oncology Core (IROC) monitoring program. If this form has been previously', 'submitted to CTSU it does not need to be resubmitted unless updates have', 'occurred at the RT facility', 'Credentialing documentation received from IROC Houston for this trial- See', 'Section 8.2 Table for details.', 'NRG-GU003', '33', 'Version Date: April 26, 2019']['Non-English Speaking Canadian and International Institutions:', '*Translation of documents is critical. The institution is responsible for all translation costs.', 'All regulatory documents, including the IRB/REB approved consent, must be provided in', 'English and in the native language. Certification of the translation is optimal but due to the', 'prohibitive costs involved NRG will accept, at a minimum, a verified translation. A verified', 'translation consists of the actual REB approved consent document in English and in the', 'native language, along with a cover letter on organizational/letterhead stationery that', 'includes the professional title, credentials, and signature of the translator as well as signed', 'documentation of the review and verification of the translation by a neutral third party. The', 'professional title and credentials of the neutral third party translator must be specified as', 'well.', 'Submitting Regulatory Documents:', 'Submit required forms and documents to the CTSU Regulatory Office, via the', 'Regulatory Submission Portal, where they will be entered and tracked in the CTSU RSS.', \"Regulatory Submission Portal: www.ctsu.org (members' area)\", 'Regulatory Tab', 'Regulatory Submission', 'When applicable, original documents should be mailed to:', 'CTSU Regulatory Office', '1818 Market Street, Suite 3000', 'Philadelphia, PA 19103', 'Institutions with patients waiting that are unable to use the Portal should alert the', 'CTSU Regulatory Office immediately at 1-866-651-2878 in order to receive further', 'instruction and support.', \"Checking Your Site's Registration Status:\", \"You can verify your site registration status on the members' section of the CTSU website.\", \"Go to https://www.ctsu.org and log in to the members' area using your CTEP-\", 'IAM username and password', 'Click on the Regulatory tab', 'Click on the Site Registration tab', 'Enter your 5-character CTEP Institution Code and click on Go', 'Note: The status given only reflects compliance with IRB documentation and institutional', 'compliance with protocol-specific requirements outlined by the Lead Network. It does', 'not reflect compliance with protocol requirements for individuals participating on the', \"protocol or the enrolling investigator's status with the NCI or their affiliated networks.\", '8.2', 'RT-Specific Pre-Registration Requirements (26-APR-2019)', 'For detailed information on the specific technology requirement required for this study,', 'please refer to the table below and utilize the web link provided for detailed instructions.', 'NRG-GU003', '34', 'Version Date: April 26, 2019']\n\n###\n\n", "completion": "END"}